{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:45:37Z","timestamp":1785861937739,"version":"3.56.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1097\/01.mbc.0000233365.10981.08","type":"journal-article","created":{"date-parts":[[2006,6,20]],"date-time":"2006-06-20T05:00:50Z","timestamp":1150779650000},"page":"353-358","source":"Crossref","is-referenced-by-count":26,"title":["Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease"],"prefix":"10.1097","volume":"17","author":[{"given":"An De","family":"Vleeschauwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Devreese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1468-0734.2001.00048.x","article-title":"Von Willebrand factor and von Willebrand disease","volume":"5","author":"Budde","year":"2001","journal-title":"Rev Clin Exp Hematol"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease. For the Subcommitte on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2516.2004.00979.x","article-title":"Von Willebrand disease: laboratory aspects of diagnosis and treatment","volume":"10","author":"Favorolo","year":"2004","journal-title":"Haemophilia"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2516.2004.00894.x","article-title":"The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctor's Organization","volume":"10","author":"Laffan","year":"2004","journal-title":"Haemophilia"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/beha.2001.0136","article-title":"Congenital von Willebrand disease type 1: definition, phenotypes, clinical and laboratory assessment","volume":"14","author":"Rodeghiero","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"R7-4-20210203","first-page":"385","article-title":"Laboratory assays for von Willeband factor: relative contribution to the diagnosis of von Willebrand's disease","volume":"29","author":"Favorolo","year":"1997","journal-title":"Pathology"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-3848(96)00161-2","article-title":"Effect of multimerization of human and recombinat von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII","volume":"84","author":"Fisher","year":"1996","journal-title":"Thromb Res"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.1989.tb00226.x","article-title":"Binding of von Willebrand factor to glycoproteins Ib and IIb\/IIIa complex: affinity is related to multimeric size","volume":"73","author":"Federici","year":"1989","journal-title":"Br J Haematol"},{"key":"R10-4-20210203","first-page":"306","article-title":"Letter: a method for asaying von Willebrand factor (ristocetin cofactor)","volume":"34","author":"Macfarlane","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0049-3848(75)90074-2","article-title":"Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregtion test","volume":"6","author":"Brinkhous","year":"1975","journal-title":"Thromb Res"},{"issue":"Suppl. 2","key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1365-2516.1998.0040s2012.x","article-title":"Laboratory diagnosis of hereditary bleeding disorders: external quality assessment","volume":"4","author":"Preston","year":"1998","journal-title":"Haemophilia"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2002-27821","article-title":"Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey","volume":"28","author":"Favorolo","year":"2002","journal-title":"Semin Thromb Haemost"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0037-1613765","article-title":"A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor","volume":"83","author":"Vanhoorelbeke","year":"2000","journal-title":"Thromb Haemost"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2002-27818","article-title":"A reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease","volume":"28","author":"Vanhoorelbeke","year":"2002","journal-title":"Semin Thromb Haemost"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1055\/s-0037-1614064","article-title":"Discrimination of von Willebrand disease (VWD) subtypes: direct comparison of von Willebrand factor:collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF-capture systems","volume":"84","author":"Favorolo","year":"2000","journal-title":"Thromb Haemost"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200607000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:45:18Z","timestamp":1785858318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200607000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000233365.10981.08","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}